Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.
2.

Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome.

Lacy BE, Levenick JM, Crowell MD.

Gastroenterol Hepatol (N Y). 2012 Oct;8(10):653-60.

PMID:
24683372
[PubMed]
Free PMC Article
3.

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

Busby RW, Kessler MM, Bartolini WP, Bryant AP, Hannig G, Higgins CS, Solinga RM, Tobin JV, Wakefield JD, Kurtz CB, Currie MG.

J Pharmacol Exp Ther. 2013 Jan;344(1):196-206. doi: 10.1124/jpet.112.199430. Epub 2012 Oct 22.

PMID:
23090647
[PubMed - indexed for MEDLINE]
Free Article
4.

Linaclotide (Linzess) for constipation.

[No authors listed]

Med Lett Drugs Ther. 2012 Nov 12;54(1403):91-2. No abstract available.

PMID:
23183319
[PubMed - indexed for MEDLINE]
5.

Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults.

Parker CH, Yuan Y, Liu LW.

Clin Med Insights Gastroenterol. 2013 Jul 31;6:21-32. doi: 10.4137/CGast.S10550. eCollection 2013. Review.

PMID:
24833940
[PubMed]
Free PMC Article
6.

Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation.

Harris LA, Crowell MD.

Curr Opin Mol Ther. 2007 Aug;9(4):403-10.

PMID:
17694454
[PubMed - indexed for MEDLINE]
7.

Pharmaceutical approval update.

Goldenberg MM.

P T. 2012 Nov;37(11):620-49. Erratum in: P T. 2012 Dec;37(12):658.

PMID:
23204815
[PubMed]
Free PMC Article
8.

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.

Johnston JM, Shiff SJ, Quigley EM.

Curr Med Res Opin. 2013 Feb;29(2):149-60. doi: 10.1185/03007995.2012.754743. Epub 2012 Dec 20. Review.

PMID:
23198977
[PubMed - indexed for MEDLINE]
9.

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.

Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR.

Gastroenterology. 2007 Sep;133(3):761-8. Epub 2007 Jul 3.

PMID:
17854590
[PubMed - indexed for MEDLINE]
10.

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.

Busby RW, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ, Tobin JV, Kurtz CB, Currie MG.

Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35. doi: 10.1016/j.ejphar.2010.09.019. Epub 2010 Sep 20.

PMID:
20863829
[PubMed - indexed for MEDLINE]
11.

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.

Johnston JM, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, O'Dea C, Baird M, Lembo AJ.

Gastroenterology. 2010 Dec;139(6):1877-1886.e2. doi: 10.1053/j.gastro.2010.08.041. Epub 2010 Aug 27.

PMID:
20801122
[PubMed - indexed for MEDLINE]
12.
13.

Pilot study on the effect of linaclotide in patients with chronic constipation.

Johnston JM, Kurtz CB, Drossman DA, Lembo AJ, Jeglinski BI, MacDougall JE, Antonelli SM, Currie MG.

Am J Gastroenterol. 2009 Jan;104(1):125-32. doi: 10.1038/ajg.2008.59.

PMID:
19098860
[PubMed - indexed for MEDLINE]
14.

[New therapeutical approaches for treatment of irritable bowel syndrome].

Siegert F, Nieber K.

Med Monatsschr Pharm. 2010 Aug;33(8):285-92; quiz 293-4. Review. German.

PMID:
21189648
[PubMed - indexed for MEDLINE]
15.

Linaclotide: first global approval.

McWilliams V, Whiteside G, McKeage K.

Drugs. 2012 Nov 12;72(16):2167-75. doi: 10.2165/11470590-000000000-00000.

PMID:
23083112
[PubMed - indexed for MEDLINE]
16.

Linaclotide: a novel approach to the treatment of irritable bowel syndrome.

Wensel TM, Luthin DR.

Ann Pharmacother. 2011 Dec;45(12):1535-43. doi: 10.1345/aph.1Q428. Epub 2011 Nov 1. Review.

PMID:
22045908
[PubMed - indexed for MEDLINE]
17.

Efficacy of linaclotide for patients with chronic constipation.

Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.

Gastroenterology. 2010 Mar;138(3):886-95.e1. doi: 10.1053/j.gastro.2009.12.050. Epub 2010 Jan 4.

PMID:
20045700
[PubMed - indexed for MEDLINE]
18.

Linaclotide in the management of gastrointestinal tract disorders.

Lacy BE, Levenick JM, Crowell MD.

Drugs Today (Barc). 2012 Mar;48(3):197-206. doi: 10.1358/dot.2012.48.3.1745228. Review.

PMID:
22462039
[PubMed - indexed for MEDLINE]
19.

Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.

Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M.

Aliment Pharmacol Ther. 2007 Mar 15;25(6):681-92.

PMID:
17311601
[PubMed - indexed for MEDLINE]
Free Article
20.

Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.

Suttor VP, Prott GM, Hansen RD, Kellow JE, Malcolm A.

Dis Colon Rectum. 2010 Feb;53(2):156-60. doi: 10.1007/DCR.0b013e3181c188e8.

PMID:
20087090
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk